Clinical Trial

Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The IBE 25-05 study will be a prospective, non-randomized, multicenter, interventional two arm evaluation designed to assess the safety and effectiveness of the GORE® EXCLUDER® IBE Plus Stent Graft in patients with common iliac artery aneurysm (CIAA) or aorto-iliac aneurysm (AIAA) disease.
Trial Details
NCT Number NCT07304102
Lead Sponsor W.L.Gore & Associates
Conditions Common Iliac Artery Aneurysm, Aorto Iliac Aneurysm
Enrollment 100 participants
Start Date 2026-09
Primary Completion 2028-03 (estimated)
Study Completion 2032-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-26